Beijing Konruns Pharmaceutical Co.,Ltd.’s Net Profit Dropped 40.8% in First Quarter of 2023

Beijing Konruns Pharmaceutical Co.,Ltd. (北京康辰药业股份有限公司) (603590.SH) reported a net profit of 29.9 million yuan in the first quarter of 2023, down 40.8% year-on-year.

Meanwhile, the company posted 165.1 million yuan in revenue, up 5.7% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 296.6 million yuan in total liabilities, with a liability-to-asset ratio of 8.2%.